دورية أكاديمية

Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data.

التفاصيل البيبلوغرافية
العنوان: Using birth-death processes to infer tumor subpopulation structure from live-cell imaging drug screening data.
المؤلفون: Wu C; Department of Industrial and Systems Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America., Gunnarsson EB; School of Mathematics, University of Minnesota, Minneapolis, Minnesota, United States of America.; Applied Mathematics Division, Science Institute, University of Iceland, Reykjavík, Iceland., Myklebust EM; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway., Köhn-Luque A; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Tadele DS; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway., Enserink JM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Frigessi A; Oslo Centre for Biostatistics and Epidemiology, Faculty of Medicine, University of Oslo, Oslo, Norway., Foo J; School of Mathematics, University of Minnesota, Minneapolis, Minnesota, United States of America., Leder K; Department of Industrial and Systems Engineering, University of Minnesota, Minneapolis, Minnesota, United States of America.
المصدر: PLoS computational biology [PLoS Comput Biol] 2024 Mar 06; Vol. 20 (3), pp. e1011888. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science, [2005]-
مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/pathology , Genetic Phenomena*, Humans ; Drug Evaluation, Preclinical
مستخلص: Tumor heterogeneity is a complex and widely recognized trait that poses significant challenges in developing effective cancer therapies. In particular, many tumors harbor a variety of subpopulations with distinct therapeutic response characteristics. Characterizing this heterogeneity by determining the subpopulation structure within a tumor enables more precise and successful treatment strategies. In our prior work, we developed PhenoPop, a computational framework for unravelling the drug-response subpopulation structure within a tumor from bulk high-throughput drug screening data. However, the deterministic nature of the underlying models driving PhenoPop restricts the model fit and the information it can extract from the data. As an advancement, we propose a stochastic model based on the linear birth-death process to address this limitation. Our model can formulate a dynamic variance along the horizon of the experiment so that the model uses more information from the data to provide a more robust estimation. In addition, the newly proposed model can be readily adapted to situations where the experimental data exhibits a positive time correlation. We test our model on simulated data (in silico) and experimental data (in vitro), which supports our argument about its advantages.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
التعليقات: Update of: ArXiv. 2023 Jun 13;:. (PMID: 37396610)
References: Cancer Discov. 2013 Dec;3(12):1416-29. (PMID: 24056683)
J Theor Biol. 2023 Jul 7;568:111497. (PMID: 37087049)
Biotechnol Rep (Amst). 2015 Apr 18;7:9-16. (PMID: 28626709)
Cell. 2014 Jan 30;156(3):603-616. (PMID: 24485463)
Oncotarget. 2016 Aug 9;7(32):51619-51625. (PMID: 27322211)
Cancer Cell. 2020 Apr 13;37(4):471-484. (PMID: 32289271)
PLoS Comput Biol. 2016 Oct 20;12(10):e1005129. (PMID: 27764087)
Cancer Discov. 2017 May;7(5):462-477. (PMID: 28331002)
Mol Pharm. 2011 Dec 5;8(6):2069-79. (PMID: 21995722)
J Theor Biol. 2020 Apr 7;490:110162. (PMID: 31953135)
Nat Commun. 2017 Nov 28;8(1):1816. (PMID: 29180633)
Leukemia. 2019 May;33(5):1291-1296. (PMID: 30679802)
Cell Rep Methods. 2023 Mar 06;3(3):100417. (PMID: 37056380)
Blood Cancer J. 2020 May 11;10(5):54. (PMID: 32393731)
Trends Cancer. 2018 Sep;4(9):634-642. (PMID: 30149881)
Nat Rev Cancer. 2012 Apr 19;12(5):323-34. (PMID: 22513401)
معلومات مُعتمدة: R01 CA241137 United States CA NCI NIH HHS
تواريخ الأحداث: Date Created: 20240306 Date Completed: 20240320 Latest Revision: 20240320
رمز التحديث: 20240320
مُعرف محوري في PubMed: PMC10947663
DOI: 10.1371/journal.pcbi.1011888
PMID: 38446830
قاعدة البيانات: MEDLINE
الوصف
تدمد:1553-7358
DOI:10.1371/journal.pcbi.1011888